DBV Technologies Outlines Regulatory Path for Viaskin : vimarsana.com

Montrouge, France, April 19, 2023 DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After Receiving Pre-BLA Responses...

Related Keywords

Montrouge , France General , France , United States , Australia , American , America , Angela Marcucci , Pharis Mohideen , Anne Pollak , Drug Administration , Exchange Commission , Company Adss , Company Phase , Outlinesregulatory Path , Viaskin Peanut , After Receiving , Nasdaq Stock Market , Daniel Tass , Human Factors , Chief Medical Officer , States Toll Free , North America , North American , Basking Ridge , Euronext Paris , Nasdaq Global Select Market , Des March , Paris Stock Exchange Dbv , Bv Technologies Sa ,